Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria

NCT06298955 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG: OMS906 study drug

Sponsor

Omeros Corporation